We previously demonstrated that cipro‰oxacin (CPX), a new quinolone antibiotic, suppresses Cyp3a in the mouse liver by reducing the hepatic level of lithocholic acid (LCA) produced by intestinal ‰ora. The present study investigated the possibility that other antibiotics with antibacterial activity against LCA-producing bacteria also cause a decrease in the LCA level in the liver, leading to reduced expression of Cyp3a11. While the mRNA expression of Cyp3a11 in the liver was signiˆcantly reduced when SPF mice were administered antibiotics such as ampicillin, CPX, levo‰oxacin, or a combination of vancomycin and imipenem, no signiˆcant changes were observed after antibiotic treatment of GF mice lacking intestinal ‰ora. LCA-producing bacteria in the feces as well as the hepatic level of the taurine conjugate of LCA were signiˆcantly reduced in the antibiotic-treated SPF mice, suggesting that the decrease in Cyp3a11 expression can be attributed to the reduction in LCA-producing intestinal ‰ora following antibiotic administration. These results suggest that the administration of antibiotics with activity against LCA-producing bacteria can also cause a decrease in the LCA level in humans, which may lower CYP3A4 expression. The intestinal ‰ora are reported to be altered not only by drugs, such as antibiotics, but also by stress, disease, and age. Theˆndings of the present study suggest that these changes in intestinal ‰ora could modify CYP expression and contribute to the individual diŠerences in pharmacokinetics. 
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